The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Jun 2019
Historique:
entrez: 3 7 2019
pubmed: 3 7 2019
medline: 23 7 2019
Statut: ppublish

Résumé

Use of sugammadex for neuromuscular block reversal is associated with fewer postoperative complications than neostigmine; however, the effects on postoperative pain outcomes are largely unknown. In this retrospective study, we investigated the relationship between neuromuscular reversal agents and postoperative pain-related outcomes following laparoscopic gastric cancer surgery.We reviewed the electronic health records of patients who underwent laparoscopic gastric cancer surgery between January 2010 and June 2017. Patients were divided into a sugammadex group and a neostigmine group, according to the neuromuscular block reversal agent used. We compared the pain outcomes in the first 3 days postoperatively (POD 0-3), length of hospital stay, and postoperative complications (Clavien-Dindo grade ≥II).During the study period, 3056 patients received sugammadex (n = 901) or neostigmine (n = 2155) for neuromuscular reversal. After propensity score matching, 1478 patients (739 in each group) were included in regression analysis. In linear regression analysis, intravenous morphine equivalent consumption (mg) during POD 0 to 3 was higher in the sugammadex group than in the neostigmine group [coefficient 103.41, 95% confidence interval (CI): 77.45-129.37; P <.001]. However, hospital stay was shorter (coefficient: -0.60, 95% CI -1.12 to -0.08; P = .025) and postoperative complication rate was lower (odds ratio: 0.20, 95% CI 0.07-0.58; P = .003) in the sugammadex group.In this retrospective study, patients undergoing laparoscopic gastric cancer surgery who received sugammadex for neuromuscular block reversal exhibited greater postoperative analgesic requirements than those who received neostigmine but had a shorter hospital stay and a lower postoperative complication rate. A randomized and blinded study should be conducted in the future to confirm the findings of the present study.

Identifiants

pubmed: 31261539
doi: 10.1097/MD.0000000000016142
pii: 00005792-201906280-00050
pmc: PMC6617163
doi:

Substances chimiques

Analgesics 0
Sugammadex 361LPM2T56
Neostigmine 3982TWQ96G

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16142

Références

Surg Obes Relat Dis. 2017 May;13(5):788-795
pubmed: 28216116
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):604-11
pubmed: 24021692
Anesth Analg. 2015 Jan;120(1):51-58
pubmed: 25625254
Healthc Inform Res. 2012 Jun;18(2):145-52
pubmed: 22844650
J Clin Anesth. 2015 Feb;27(1):51-6
pubmed: 25544263
World J Surg. 2016 Dec;40(12):2898-2903
pubmed: 27405749
Anaesthesia. 2012 Sep;67(9):991-8
pubmed: 22698066
J Clin Anesth. 2016 Dec;35:1-12
pubmed: 27871504
Surg Laparosc Endosc Percutan Tech. 2014 Oct;24(5):420-3
pubmed: 24752165
J Am Coll Surg. 2009 Feb;208(2):186-92
pubmed: 19228529
J Vis Exp. 2013 Jun 25;(76):
pubmed: 23851450
Nurs Res. 1982 Jul-Aug;31(4):236-8
pubmed: 7048260
J Adv Res. 2017 Sep;8(5):495-511
pubmed: 28748116
Br J Anaesth. 2017 Jun 1;118(6):834-842
pubmed: 28575335
Palliat Med. 2011 Jul;25(5):504-15
pubmed: 21708857
Pain. 2008 Aug 31;138(2):375-379
pubmed: 18291584
Minerva Anestesiol. 2018 Apr;84(4):509-514
pubmed: 29239154
Br J Surg. 2011 Jul;98(7):991-5
pubmed: 21538340
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912

Auteurs

Tak Kyu Oh (TK)

Department of Anesthesiology and Pain Medicine.

Eunjeong Ji (E)

Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Hyo-Seok Na (HS)

Department of Anesthesiology and Pain Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH